Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective

• मुख्य लेखकों: Shah D (लेखक), Risebrough NA (लेखक), Perdrizet J (लेखक), Iyer NN (लेखक), Gamble C (लेखक), Dang-Tan T (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Dove Medical Press, 2018-11-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Dhvani Shah,1 Nancy A Risebrough,2 Johnna Perdrizet,1 Neeraj N Iyer,3 Cory Gamble,4 Tam Dang-Tan3 1ICON, Commercialisation and Outcomes, Health Economics, New York, NY, USA; 2ICON, Commercialisation and Outcomes, Health Economics, Toronto, ON, Canada; 3HEOR & Data Analytics, Novo Nordisk Inc, Pl...